Daniel Cagney - Concepedia

Author

Daniel Cagney

Also Known As

D Cagney, D N Cagney, D. Cagney, D. N. Cagney, D.N. Cagney, Daniel Cagney, Daniel N Cagney, Daniel N. Cagney, Monica Krishnan

119

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Dana-Farber Brigham Cancer Center Harvard University Brigham and Women's Hospital Massachusetts General Hospital

About

Daniel Cagney is an author at Dana-Farber Cancer Institute specializing in medicine, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.2K
2	Health Sciences	10	10	656
3	Gastroenterology	3	3	87
4	Biostatistics	1	1	140
5	Emergency Medicine	1	1	14

Daniel Cagney

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Daniel Cagney, Allison Martin, Paul J. Catalano, Neuro-Oncology	2017	803
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient Paul W. Sperduto, Shane Mesko, Jing Li, Journal of Clinical Oncology	2020	424
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation Allison Martin, Daniel Cagney, Paul J. Catalano, JAMA Oncology Brain Metastases TreatedNeuro-oncologyRadiation MedicineOncologyRenal Cell Carcinoma	2018	299
Brain Metastases in Newly Diagnosed Breast Cancer Allison Martin, Daniel Cagney, Paul J. Catalano, JAMA Oncology	2017	298
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases Chad G. Rusthoven, Masaaki Yamamoto, Denise Bernhardt, JAMA Oncology	2020	194
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors Luke Pike, Andrew Bang, Brandon A. Mahal, International Journal of Radiation OncologyBiologyPhysics Cancer ImmunosurveillanceRadiation TherapyMedicineImmunologyImmune Checkpoint Inhibitor	2018	177
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy Andrew Bang, T.J. Wilhite, Luke Pike, International Journal of Radiation OncologyBiologyPhysics Cancer TherapeuticsRadiation TherapyMedicineImmunologyMulticenter Evaluation	2017	158
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) Camille Verry, Sandrine Dufort, Julie Villa, Radiotherapy and Oncology	2021	141
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today Paul W. Sperduto, Shane Mesko, Jing Li, International Journal of Radiation OncologyBiologyPhysics Prognostic EvaluationBreast OncologyMedicinePrognosisPrognostic Index	2020	140
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors Paul W. Sperduto, Brian De, Jing Li, International Journal of Radiation OncologyBiologyPhysics Prognostic AssessmentPrognostic BiomarkersPrognostic EvaluationBrain MetastasesMedicine	2022	107

Page 1